Mera Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2020	FY 2019	FY 2011	FY 2010	FY 2009
Period Ending	Aug '25 Aug 14, 2025	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '11 Oct 31, 2011	Oct '10 Oct 31, 2010	Oct '09 Oct 31, 2009
Market Capitalization	0	0	0	1	2	3
Market Cap Growth	-99.25%	66.67%	-84.75%	-33.33%	-40.00%	7.33%
Enterprise Value	-	1	0	1	2	3
Last Close Price	0.00	0.00	0.00	0.00	0.00	0.01
PS Ratio	-	-	-	3.62	5.69	4.57
PB Ratio	-1.39	-9.35	-6.91	-1.27	-2.43	-19.69
P/OCF Ratio	-	-	-	-	192.09	-
EV/Sales Ratio	-	-	-	3.79	5.87	4.64
Debt / Equity Ratio	-	-	-	-0.35	-0.33	-0.37
Asset Turnover	-	-	-	4.20	1.75	1.84
Quick Ratio	-	-	-	0.01	0.02	0.03
Current Ratio	-	-	-	0.06	0.02	0.07
Return on Assets (ROA)	-	-	-	-174.48%	-89.65%	-38.69%
Return on Capital Employed (ROCE)	26.60%	18.80%	23.10%	23.30%	35.10%	145.10%
Earnings Yield	-19.16%	-2.00%	-3.34%	-17.13%	-32.73%	-7.04%
FCF Yield	-	-	-	-6.77%	-8.61%	-1.85%
Buyback Yield / Dilution	-1.83%	-	-1.74%	-	-0.09%	-5.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.